2 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow TOTUM-63: new trials by email Literature Review of TOTUM-63 trials Research Report on TOTUM-63
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk TOTUM-63 - Prediabetic State, Dysglycemia | Not applicable | Completed | Valbiotis | 20 | 2022-04-25 | 2023-11-13 |
| Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes Totum-63, Placebo - Prediabetes, Type 2 Diabetes | Phase 2 / Phase 3 | Completed | Valbiotis | 66 | 2016-10-01 | 2020-10-05 |
Obesity (2) · Prediabetic State (2) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Hypertriglyceridemia (1) · Insulin Resistance (1) · Overweight (1)
Valbiotis (2)
Canada (1) · France (1) · Ireland (1) · Serbia (1) · Slovenia (1)